MedTrace Logo

Psychometric Properties of IntelliSpace Cognition

NCT03801382 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2023-06-22

Study results available
· View outcomes & findings →

Summary

This study aims to validate the tests that are on the IntelliSpace Cognition platform and to establish normative data for these tests.

Conditions

  • Cognitive Functioning of Healthy Individuals

Interventions

DEVICE

IntelliSpace Cognition (ISC)

Philips ISC is a Class-II Medical Device in the US and provides objective data regarding cognition via scoring algorithms that HCPs can use to inform diagnostic decision making and treatment planning. It enables tracking cognition over time and offers the possibility of new outcome measures. ISC can be used in a variety of healthcare environments such as neurology and neuropsychology practices.

DIAGNOSTIC_TEST

Paper-Pencil Tests

The same cognitive tests that are on the ISC platform are performed using paper and pencil (rather than digitally) as is the case in standard clinical practice.

Sponsors & Collaborators

  • Research America Inc.

    collaborator INDUSTRY

  • Qserve

    collaborator INDUSTRY

  • Factory CRO

    collaborator INDUSTRY

  • Philips Electronics Nederland B.V. acting through Philips CTO organization

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-15
Primary Completion
2019-08-26
Completion
2019-08-26
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03801382 on ClinicalTrials.gov